Epistaxis. Haemorrhage from nose
Conditions
Interventions
Treatment - Drugs
Tranexamic Acid: Ampoule, 100mg/ml, Local, the wick is soaked in 5cc of solution.
Sponsors
Research Council of Tabriz Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion Criteria: All patients with epistaxis referring to the emergency department. Exclusion Criteria: multiple traumas; shock; Lack of patient's satisfaction; INR> 1.5
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bleeding control time. Timepoint: every 5 minutes from the start point until the bleeding stops. Method of measurement: measured by stopwatch, per minute.;Bleeding recurrence. Timepoint: first 24 hours and the first week. Method of measurement: measured by watch.;Patient's satisfaction. Timepoint: within discharge. Method of measurement: by VAS measurment system (10 points mark). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Morteza Saeedi
Tehran University of Medical Sciences
Outcome results
None listed